Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maciej Kzrakowski
Institution:
The Maria Sklodowska-Curie National Research Institute of Oncology
Observed institution:
The Maria Sklodowska-Curie National Research Institute of Oncology
OpenAlex ID:
A5020097422
Abstract CT199: IMpower133: Primary efficacy and safety + CNS-related adverse events in a Ph1/3 study of first-line (1L) atezolizumab (atezo) + carboplatin + etoposide in extensive-stage SCLC (ES-SCLC)
2019
·
Aaron S. Mansfield
, Stephen V. Liu
, et al.
·
Cancer Research
·
5
Abstract CT199: IMpower133: Primary efficacy and safety + CNS-related adverse events in a Ph1/3 study of first-line (1L) atezolizumab (atezo) + carboplatin + etoposide in extensive-stage SCLC (ES-SCLC)
2019
·
Aaron S. Mansfield
, Stephen V. Liu
, et al.
·
Clinical Trials
Show more works
View as search
Works count:
2
Citation count:
5
H-index:
1
I10-index:
Year
Topic
Type
